Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Herantis Pharma

Explore full profile

Innovative biotech company developing disease modifying therapies for Parkinson’s disease

Helsinki, FinlandFounded 2008Biotech & Life Sciences
Valuation $28M Market cap · 2020
Revenue $28K Latest reported FY

About Herantis Pharma

Herantis Pharma PLC is a biotech company developing disease-modifying therapies for Parkinson's disease. The company's current development program focuses solely on HER-096, which is a peptidomimetic molecule designed to retain the biological activity of the neuroprotective CDNF protein. Keywords: Pharmaceuticals and Biotechnology, Biologics, Biotech, Drug Development Firm, Drugs Researchers, Neurodegenerative Diseases, Neurodegenerative Diseases Drugs, Neurodegenerative Diseases Medicine.

Source: Dealroom company data

At a glance

Status
Listed
Founded
2008
Headquarters
Helsinki, Finland
Listing
IPO 2014
Sector
Biotech & Life Sciences

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed3 investors entered at this stage

  • European Innovation Council
  • Parkinson's Virtual Biotech
  • Michael J. Fox Foundation for Parkinson's Research

Series A2 investors entered at this stage

  • Finnvera Venture Capital
  • VNT Management

Series B and later1 investor entered at this stage

  • EIC Fund

Talent

Book a demo to see the people
Team profiled 10 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
4 countries with
team presence
🇫🇮 Finland78.6%
🇮🇹 Italy7.1%
🇺🇸 United States7.1%
🇩🇰 Denmark7.1%
4 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Herantis Pharma on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Herantis Pharma on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles